Myhep LVIR (Ledipasvir/Sofosbuvir)

Price range: $308.00 through $882.00

Myhep LVIR (Ledipasvir/Sofosbuvir)
Variation Price Price / Unit Quantity Add To Cart
28 Tablet/s $308.00 $11/ Piece
56 Tablet/s $605.00 $10.8/ Piece
84 Tablet/s $882.00 $10.5/ Piece
SKU: Myhep LVIR (Ledipasvir/Sofosbuvir) Categories: ,

Description

Myhep LVIR (Ledipasvir/Sofosbuvir) – Effective Treatment for Chronic Hepatitis C Virus (HCV) Infection

Myhep LVIR is a prescription antiviral medicine formulated with a combination of Ledipasvir 90mg and Sofosbuvir 400mg, two active ingredients widely used for the treatment of chronic Hepatitis C Virus (HCV) infection in adults. It belongs to the class of Direct-Acting Antiviral (DAA) medicines that work by targeting specific proteins required for the replication and survival of the Hepatitis C virus.

Ledipasvir works by inhibiting the HCV NS5A protein, while Sofosbuvir blocks the HCV NS5B polymerase enzyme, preventing the virus from multiplying. This combination helps reduce the viral load and supports the body’s ability to clear the infection. The medicine is prescribed based on the patient’s HCV genotype, liver condition, previous treatment history, and overall health status.

Myhep LVIR should only be used under the guidance of a qualified healthcare professional. Proper diagnosis, medical monitoring, and adherence to the prescribed treatment schedule are important for achieving the best therapeutic results.

  • Key Features
  1. Contains Ledipasvir 90mg + Sofosbuvir 400mg per tablet
  2. Direct-Acting Antiviral (DAA) combination therapy
  3. Used for the treatment of chronic Hepatitis C Virus (HCV) infection
  4. Helps inhibit viral replication through dual antiviral action
  5. Once-daily oral tablet for convenient administration
  6. Manufactured under quality pharmaceutical standards

How to Take Myhep LVIR

For the best treatment outcome, take Myhep LVIR exactly as prescribed by your healthcare provider. The tablet is generally taken once daily with water and may be taken with or without food unless instructed otherwise.

Swallow the tablet whole without crushing, chewing, or splitting it unless advised by your doctor. Take the medicine at the same time each day to maintain consistent drug levels in the body.

Do not stop treatment early or change the dose without medical advice, as incomplete therapy may reduce effectiveness and increase the risk of treatment failure.

  • General Dosage Reference
Medical ConditionRecommended Adult Dose
Chronic Hepatitis C Virus (HCV) Infection1 tablet once daily (Ledipasvir 90mg + Sofosbuvir 400mg)
HCV Genotype-Specific TreatmentDuration and therapy plan based on physician recommendation
Patients with Liver CirrhosisIndividualized treatment according to medical evaluation
Previously Treated HCV PatientsAs directed by the treating physician

The exact dosage and treatment duration should always be determined by your healthcare provider based on HCV genotype, liver health, treatment history, and clinical response.

Safety Information

Before starting Myhep LVIR, inform your healthcare provider if you have liver disease, kidney problems, hepatitis B infection, or any known allergy to Ledipasvir or Sofosbuvir. Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins, and herbal supplements you are taking to avoid possible drug interactions.

Patients who are pregnant, planning pregnancy, or breastfeeding should consult their doctor before using this medicine. Your healthcare provider will decide whether this treatment is appropriate based on your medical condition.

Common side effects may include headache, tiredness, nausea, weakness, diarrhea, insomnia, or dizziness. Seek immediate medical attention if you experience severe allergic reactions, breathing difficulty, swelling of the face or throat, or other serious symptoms.

Product Specifications

SpecificationInformation
BrandMyhep LVIR
Generic NameLedipasvir/Sofosbuvir
Active IngredientsLedipasvir 90mg + Sofosbuvir 400mg
Strength90mg/400mg
Dosage FormOral Tablet
Drug ClassDirect-Acting Antiviral (DAA)
Route of AdministrationOral
Therapeutic UseChronic Hepatitis C Virus (HCV) Infection
Prescription StatusPrescription Required
StorageStore below 30°C

Frequently Asked Questions

What is Myhep LVIR used for?
Myhep LVIR is used for the treatment of chronic Hepatitis C Virus (HCV) infection in adults as part of antiviral therapy.

How does Myhep LVIR work?
It combines Ledipasvir and Sofosbuvir, which block different proteins involved in HCV replication, helping prevent the virus from multiplying.

Is Myhep LVIR an antibiotic?
No. Myhep LVIR is an antiviral medicine and is not used to treat bacterial infections.

Can Myhep LVIR be taken alone?
Myhep LVIR is a complete antiviral combination tablet, but the treatment plan and duration should be decided by a healthcare provider.

How long does Myhep LVIR treatment take?
Treatment duration depends on factors such as HCV genotype, liver condition, previous treatment history, and response to therapy.

Can I purchase Myhep LVIR online?
Availability depends on your country’s regulations. A valid prescription may be required before purchase.

What should I do if I miss a dose?
Take the missed dose as soon as you remember if it is close to your usual schedule. Do not take two doses together. Consult your healthcare provider if you are unsure.

Additional information

Quantity Value

28 Tablet/s, 56 Tablet/s, 84 Tablet/s

Reviews

There are no reviews yet.

Be the first to review “Myhep LVIR (Ledipasvir/Sofosbuvir)”